Arvato Systems Migrates Medicines Verification System to Oracle Cloud in Europe
What happened
Arvato Systems is using Oracle EU Sovereign Cloud to support prescription medicine verification across 15 European countries. By migrating its National Medicines Verification System (NMVS) from on-premises infrastructure, Arvato Systems has improved the performance, availability, and scalability of this mission-critical healthcare service. The NMVS enables supply chain participants to verify the authenticity of prescription medicines to prevent counterfeits.
From webwire.com
Why it matters
The deployment supports the EU medicines verification framework and helps meet strict EU data residency and privacy requirements. This migration allows Arvato Systems to streamline operations and efficiently scale its services across multiple European nations.
Oracle is providing data centers for AI workloads in Europe, with the deployment subject to EU redundancy rules.
From webwire.com
Who's involved
- Arvato SystemsUses Oracle's EU Sovereign Cloud to provide services for medicines verification across 15 European countries.
- OracleProvides the EU Sovereign Cloud platform utilized by Arvato Systems for mission-critical services.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Arvato SystemsSpeculative
Could expand its operational footprint and validate its service model across 15 European countries, potentially increasing revenue.
Keep exploring
The entities involved
-
Arvato Systems
Internationally active IT specialist
Nothing else this week.
-
Europe
terrestrial continent located in north-western Eurasia
-
Oracle
company in Madrid, Spain
Related events
- Alibaba Group plans to establish cloud regions in Europe.
- Claro facilities are hosting the infrastructure for Oracle's cloud region in Colombia.
- European companies are using major cloud services from US providers, prompting the European Commission to seek ways to reduce risky dependencies.
- The European Commission is examining Oracle's software licensing practices.